Awaiting Parliament 1st reading / single reading / budget 1st stage
Next event: Vote in plenary scheduled 2017/04/27 more...
- Vote in committee, 1st reading/single reading 2017/03/22
- Committee report tabled for plenary, single reading 2017/03/28
- Debate in Parliament 2017/04/26
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | AYALA SENDER Inés (S&D) | ZDECHOVSKÝ Tomáš (EPP), FITTO Raffaele (ECR), ALI Nedzhmi (ALDE), DE JONG Dennis (GUE/NGL), JÁVOR Benedek (Verts/ALE), VALLI Marco (EFD), KAPPEL Barbara (ENF) |
Opinion | ENVI | LA VIA Giovanni (EPP) |
Activites
-
2017/04/27
Vote in plenary scheduled
-
2017/04/26
Debate in Parliament
-
2017/03/28
Committee report tabled for plenary, single reading
-
A8-0084/2017
summary
The Committee on Budgetary Control adopted the report by Inés AYALA SENDER (S&D, ES) on discharge in respect of the implementation of the budget of the European Medicines Agency (EMA) for the financial year 2015. The committee called on the European Parliament to grant the Executive Director of the Agency discharge in respect of the implementation of the agency’s budget for the financial year 2015. Noting that the Court of Auditors stated that it had obtained reasonable assurance that the annual accounts of the Agency for the financial year 2015 were reliable and that the underlying transactions were legal and regular, Members called on Parliament to approve the closure of the Agency’s accounts. They made, however, a number of recommendations that needed to be taken into account when the discharge is granted, in addition to the general recommendations that appear in the draft resolution on performance, financial management and control of EU agencies: Agency’s financial statements: Members note the final budget of the European Medicines Agency for the financial year 2015 was EUR 308 097 000 representing an increase of 9.07 % compared to 2014. Prevention and management of conflicts of interests and transparency: Members acknowledged that the revised policy on the handling of declarations of interests of scientific committees’ members and experts entered into force in 2015. They reminded the Agency that Directive 2003/63/EC states that medicines can only be considered for Union marketing authorisation if they have been tested in accordance with ethical guidelines. They also reminded it of its commitment to perform extra checks on clinical trials carried out outside the European Union before granting a drug market authorisation. The Agency is asked to report to the discharge authority every year on actions taken to ensure drugs for the Union market were tested ethically. Members also made a series of observations regarding the budgetary and financial management, commitments and carry-overs, transfers, procurement and recruitment procedures, the prevention and management of conflicts of interests and internal audits and controls. Impact of Brexit: on 23 June 2016, the citizens of the United Kingdom voted to leave the European Union. Members noted that following the outcome of the UK referendum on 23 June 2016, the Agency established a dedicated task force to focus on relocation preparedness, operational and financial preparedness, HR-related matters and communication (internal and external) aspects. They observed that the work currently ongoing is focussed on the impact of a loss of EMA staff in the event of relocation and loss of external expertise due to the potential unavailability of UK expertise in the scientific committees and other EMA fora. An impact assessment including remedial solutions should be available by the end of the first quarter of 2017. Lastly, Members noted with concern that the Agency’s rental contract until 2039 does not include an early termination clause to release the Agency from the liabilities of rent and associated costs, and that the payable rent for the remaining period from 2017 to 2039 is estimated at EUR 347.6 million. They asked the Agency to report to the discharge authority on any developments on this matter.
-
A8-0084/2017
summary
-
2017/03/22
Vote in committee, 1st reading/single reading
-
2016/10/04
Committee referral announced in Parliament, 1st reading/single reading
-
2016/07/11
Non-legislative basic document published
-
COM(2016)0475
summary
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2015, as part of the 2015 discharge procedure. Analysis of the accounts of the European Medicines Agency (EMA). CONTENT: the organisational governance of the EU consists of institutions, agencies and other EU bodies whose expenditure is included in the general budget of the Union. The EU's operational expenditure of these institutions takes different forms, depending on how the money is paid out and managed. From 2014 onwards, the Commission classifies its expenditure as follows: Direct management: the budget is implemented directly by the Commission services. Indirect management: the Commission confers tasks of implementation of the budget to bodies of EU law or national law, such as the EU agencies. Shared management: under this method of budget implementation tasks are delegated to Member States. About 80 % of the expenditure falls under this management mode covering such areas as agricultural spending and structural actions. This Commission document concerns the EU's consolidated accounts for the year 2015 and details how spending by the EU institutions and bodies was carried out. The consolidated annual accounts of the EU provide financial information on the activities of the institutions, agencies and other bodies of the EU from an accrual accounting and budgetary perspective. It is the responsibility of the Commission's Accounting Officer to prepare the EU's consolidated annual accounts and ensure that they present fairly, in all material aspects, the financial position, the result of the operations and the cashflows of the EU institutions and bodies, including the European Medicines Agency (EMA), with a view to granting discharge. Discharge procedure: the final step of a budget lifecycle is the discharge of the budget for a given financial year. It represents the political aspect of the external control of budget implementation and is the decision by which the European Parliament, acting on a Council recommendation, "releases" the Commission (and other EU bodies) from its responsibility for management of a given budget by marking the end of that budget's existence. The European Parliament is the discharge authority within the EU. The discharge procedure may produce three outcomes: (i) the granting; (ii) postponement or; (iii) the refusal of the discharge. The final discharge report including specific recommendations to the Commission for action is adopted in plenary by the European Parliament and are subject to an annual follow up report in which the Commission outlines the concrete actions it has taken to implement the recommendations made. Each agency is subject to its own discharge procedure, including the European Medicines Agency (EMA). The European Medicines Agency: the Agency, which is located in London (UK), was created by Council Regulation (EEC) No 2309/93, which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council and its role is the coordination of the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use on the basis of a centralised procedure. As regards Agency’s accounts, these are presented in detail in the document on the consolidated annual accounts of the European Union for 2015: Commitment appropriations: - committed: EUR 308 million; - paid: EUR 290 million; - carried-over: EUR 6 million. Payment appropriations: - committed: EUR 349 million; - paid: EUR 291 million; - carried-over: EUR 43 million. For further details on expenditure, please refer to the final accounts of the EMA.
- DG {'url': 'http://ec.europa.eu/info/departments/budget_en', 'title': 'Budget'}, GEORGIEVA Kristalina
-
COM(2016)0475
summary
Documents
- Non-legislative basic document published: COM(2016)0475
- Committee report tabled for plenary, single reading: A8-0084/2017
History
(these mark the time of scraping, not the official date of the change)
activities/4/type |
Old
Debate in plenary scheduledNew
Debate in Parliament |
activities/3/docs/0/text |
|
activities/3/docs |
|
activities/4/type |
Old
Indicative plenary sitting date, 1st reading/single readingNew
Debate in plenary scheduled |
activities/5 |
|
activities/3 |
|
procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament 1st reading / single reading / budget 1st stage |
activities/2/committees |
|
activities/2/type |
Old
Vote scheduled in committee, 1st reading/single readingNew
Vote in committee, 1st reading/single reading |
activities/3 |
|
activities/2/date |
Old
2017-03-23T00:00:00New
2017-03-22T00:00:00 |
activities/0/docs/0/celexid |
CELEX:52016DC0475:EN
|
activities/0/docs/0/celexid |
CELEX:52016DC0475:EN
|
activities/0/commission/0/DG/url |
Old
http://ec.europa.eu/dgs/budget/New
http://ec.europa.eu/info/departments/budget_en |
activities/1/committees/0/shadows/6/mepref |
Old
53b2d70eb819f205b0000008New
53b2dbc9b819f205b0000096 |
activities/1/committees/0/shadows/6/name |
Old
ALIOT LouisNew
KAPPEL Barbara |
committees/0/shadows/6/mepref |
Old
53b2d70eb819f205b0000008New
53b2dbc9b819f205b0000096 |
committees/0/shadows/6/name |
Old
ALIOT LouisNew
KAPPEL Barbara |
other/0/dg/url |
Old
http://ec.europa.eu/dgs/budget/New
http://ec.europa.eu/info/departments/budget_en |
activities/0/docs/0/text |
|
activities/1 |
|
activities/2/committees |
|
activities/2/date |
Old
2016-10-04T00:00:00New
2017-03-23T00:00:00 |
activities/2/type |
Old
Committee referral announced in Parliament, 1st reading/single readingNew
Vote scheduled in committee, 1st reading/single reading |
committees/0/shadows/0 |
|
committees/0/shadows/1 |
|
committees/0/shadows/2 |
|
committees/0/shadows/4 |
|
committees/0/shadows/5 |
|
committees/0/shadows/6 |
|
activities/1 |
|
procedure/dossier_of_the_committee |
CONT/8/07467
|
procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |
activities/0/commission/0 |
|
other/0 |
|
committees/1/date |
2016-08-31T00:00:00
|
committees/1/rapporteur |
|
activities |
|
committees |
|
links |
|
other |
|
procedure |
|